Insider · CIK 0001728897
Mark Jeanfreau
Files at RNST (RENASANT CORP). First filing Feb 3, 2026, latest Feb 3, 2026.
In brief
Mark Jeanfreau files SEC Form 4 as officer at RNST (RENASANT CORP). Since Feb 3, 2026, Mark Jeanfreau has reported 0 open-market buys worth $0 and 1 open-market sell worth $227k, the latest filed on Feb 3, 2026.
A track record needs three past buys with six months of prices behind them; Mark Jeanfreau has 0, so none is measured yet.
The newest scored trade: sold $227k of RNST on Feb 2, 2026, filed Feb 3, 2026, scored 43 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $227k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RNST: RENASANT CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | RENASANT CORP | $227k 6,000 shares | -8% | +39% from low-4% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 2, 2026 | RNST RENASANT CORP | 6,000 0.01% of outstanding | $230k | Feb 2, 2026 | none |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | RNST RENASANT CORP | DDisposition to issuer Common Stock | -1,697 | $0.00 | $0 | 63,475 | Mar 23, 2026 |
| Mar 19, 2026 | RNST RENASANT CORP | FTax withholding Common Stock | -3,302 | $34.39 | $114k | 60,173 | Mar 23, 2026 |
| Feb 2, 2026 | RNST RENASANT CORP | SOpen-market sale Common Stock | -6,000 | $37.88 | $227k | 65,172 | Feb 3, 2026 |
| Jan 1, 2026 | RNST RENASANT CORP | AGrant or award Common Stock | +6,862 | $0.00 | $0 | 64,219 | Jan 5, 2026 |
| Jan 1, 2026 | RNST RENASANT CORP | AGrant or award Common Stock | +6,862 | $0.00 | $0 | 71,081 | Jan 5, 2026 |
| Mar 4, 2025 | RNST RENASANT CORP | DDisposition to issuer Common Stock | -430 | $0.00 | $0 | 61,317 | Mar 5, 2025 |
| Mar 4, 2025 | RNST RENASANT CORP | FTax withholding Common Stock | -4,387 | $36.20 | $159k | 56,930 | Mar 5, 2025 |
| Jan 1, 2025 | RNST RENASANT CORP | AGrant or award Common Stock | +6,885 | $0.00 | $0 | 54,757 | Jan 2, 2025 |
| Jan 1, 2025 | RNST RENASANT CORP | AGrant or award Common Stock | +6,885 | $0.00 | $0 | 61,642 | Jan 2, 2025 |
| Mar 28, 2024 | RNST RENASANT CORP | DDisposition to issuer Common Stock | -1,652 | $0.00 | $0 | 50,323 | Mar 28, 2024 |
| Mar 28, 2024 | RNST RENASANT CORP | FTax withholding Common Stock | -2,862 | $31.11 | $89k | 47,461 | Mar 28, 2024 |
| Jan 1, 2024 | RNST RENASANT CORP | AGrant or award Common Stock | +5,548 | $0.00 | $0 | 46,427 | Jan 3, 2024 |
| Jan 1, 2024 | RNST RENASANT CORP | AGrant or award Common Stock | +5,548 | $0.00 | $0 | 51,975 | Jan 3, 2024 |
Questions about Mark Jeanfreau
Answered from the filings on this page, as of the latest one.
Is Mark Jeanfreau buying or selling?
In the last 12 months Mark Jeanfreau reported 0 open-market buys worth $0 and 1 open-market sell worth $227k on SEC Form 4; the latest was sold $227k of RNST on Feb 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Mark Jeanfreau's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark Jeanfreau has 0.
Where does Mark Jeanfreau file Form 4?
Mark Jeanfreau has filed Form 4 at RNST (RENASANT CORP) as EVP/General Counsel. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.